Skip to main content
. 2021 May 21;16(5):e0252082. doi: 10.1371/journal.pone.0252082

Table 4. Association between COL6A4P2 polymorphism and tumor staging of lung cancer.

SNP ID Model Genotype Control Case OR (95%CI) p
rs77941834 Codominant TT 57 210 1.00
TA 23 46 0.52 (0.29–0.94) 0.030
AA 4 5 0.33 (0.09–1.31) 0.116
Dominant TT 57 210 1.00
TA/AA 27 51 0.49 (0.28–0.86) 0.013
Recessive TT/TA 80 256 1.00
AA 4 5 0.39 (0.10–1.49) 0.167
Log-additive 0.55 (0.34–0.87) 0.011

SNP = single nucleotide polymorphism; OR = odds ratio; 95%CI = 95% confidence interval.

p < 0.05 indicates statistical significance.

Bold values indicate a significant difference.